24. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
30.11. - 01.12.2017, Erfurt
Abstracts
Meeting Abstract
(17gaa85)
[Volltext]
Use of aldosterone antagonists at the University hospital Jena
Farker K, Weber J, Wende B, Hartmann M[Volltext]
Meeting Abstract
(17gaa86)
[Volltext]
Risk factors for electrolyte disturbances in hospitalized geriatric patients – focus on diuretics
Börner J, Baum S, Krummenauer F, Schaper K, Thürmann PA[Volltext]
Meeting Abstract
(17gaa87)
[Volltext]
Methods of application of statutory health insurance routine data: Morbidity Related Groups (MRG) in outpatient treatment and its relations to ICD-10 diagnoses
Schuster R, Heidbreder M, von Arnstedt E, Ostermann T, Emcke T[Volltext]
Meeting Abstract
(17gaa88)
[Volltext]
Application of statutory health insurance data: analysis of age and gender structures for ICD-10 diagnoses in outpatient treatment
Schuster F, Ostermann T, Emcke T, Schuster R[Volltext]
Meeting Abstract
(17gaa89)
[Volltext]
Identification of drug-related problems by means of pharmacy-based medication review – results of a project to optimise medication safety
Sell R, Schaefer M[Volltext]
Meeting Abstract
(17gaa90)
[Volltext]
Utilizing health insurance routine data: an overview of methods, algorithms and fields of application in the federal state of Schleswig-Holstein
Schuster R, Heidbreder M, Schuster F, von Arnstedt E, Ostermann T, Schuster M, Emcke T[Volltext]
Meeting Abstract
(17gaa91)
[Volltext]
Incidence and management of adverse drug reactions in an outpatient setting – a cross-sectional analysis
Haase A, Weckmann G, Alte D, Chenot JF[Volltext]
Meeting Abstract
(17gaa92)
[Volltext]
Drug Safety – The Contribution of Community Pharmacies in the Pharmacovigilance System
Wessel T, Pixberg T, Mischok M, Erzkamp S, Puteanus U[Volltext]
Meeting Abstract
(17gaa93)
[Volltext]
General Practitioners' Perception of Interprofessional Collaboration with Pharmacists
Rose O, Richling K, Köberlein-Neu J[Volltext]
Meeting Abstract
(17gaa94)
[Volltext]
Delphi meets AMBER – An expert survey on medication-related problems in nursinghomes
Erzkamp S, Rose O[Volltext]
Meeting Abstract
(17gaa95)
[Volltext]
Combined use of medicines affecting the renin-angiotensin system: dual RAS blockade in German nursing home residents
Dörks M, Herget-Rosenthal S, Hoffmann F, Jobski K[Volltext]
Meeting Abstract
(17gaa96)
[Volltext]
Intake of sleep disturbing and sleep inducing drugs – an interaction analysis on the additive scale.
Lehnich AT, Kowall B, Moebus S, Jöckel KH, Stang A[Volltext]
Meeting Abstract
(17gaa97)
[Volltext]
The impact of new product entry on adherence to disease-modifying therapy for multiple sclerosis in Germany
Blankart K, Frey S, Lichtenberg F[Volltext]
Meeting Abstract
(17gaa98)
[Volltext]
Drug interactions in community-dwelling people screened positive for dementia: Data from the DelpHi study
Wucherer D, Thyrian R, Hertel J, Michalowsky B, Zwingmann I, Kilimann I, Teipel S, Hoffmann W[Volltext]
Meeting Abstract
(17gaa99)
[Volltext]
Regional distributions of biosimilar rates of the private health insurance
Jacke C, Wild F[Volltext]
Meeting Abstract
(17gaa100)
[Volltext]
Pneumococcal vaccination rates in immunocompromised patients in Germany
Schmedt N, Kossack N, Sprenger R, Schiffner-Rohe J, Walker J, Häckl D[Volltext]
Meeting Abstract
(17gaa101)
[Volltext]
The effect of pharmaceutical advice by phone regarding inappropriate drug prescriptions
van Eijk SC, Arndt LK, Neitemeier S[Volltext]
Meeting Abstract
(17gaa102)
[Volltext]
Antibiotic use among Turkish migrants in Germany: knowledge, attitudes and patient-provider interaction
Erdsiek F, Brzoska P, Aksakal T[Volltext]
Meeting Abstract
(17gaa104)
[Volltext]
Innovationsfondsprojekte AdAM und RESIST
Jachmich J, Hammerschmidt R, Meyer F[Volltext]
Meeting Abstract
(17gaa105)
[Volltext]
The moderating role of allergy immunotherapy in asthma progression
Tesch F, Wüstenberg E, Mücke V, Küster D, Schmitt J[Volltext]
Meeting Abstract
(17gaa106)
[Volltext]
Prescription Behavior in the Context of Benefit Assessment Exemplified in the Federal State of Germany, Schleswig-Holstein
Heidbreder M, von Arnstedt E, Emcke T, Schuster R[Volltext]
Meeting Abstract
(17gaa107)
[Volltext]
Prescription of oral anticoagulant drugs in the German federal state of Schleswig- Holstein; is there a regional pattern?
von Arnstedt E, Heidbreder M, Emcke T, Schuster R[Volltext]
Meeting Abstract
(17gaa108)
[Volltext]
Improving the care of children and adolescents with medicines by enhancing medication safety - The KiDSafe Project
Neubert A, Schwab M, Riedel C, Urschitz M, Zepp F, Romanos M, Bertsche T, Kiess W, Wenzl T, Haug U, Verheyen F, Rascher W[Volltext]
Meeting Abstract
(17gaa109)
[Volltext]
Methodological Challenges Using Drug Prescription Data
Swart E[Volltext]
Meeting Abstract
(17gaa110)
[Volltext]
Impact of a European Referral Process on the Prescription Volume of combined hormonal contraceptives
Selke Krulichová I, Selke GW, Eichler U, Lappe V, Schubert I[Volltext]
Meeting Abstract
(17gaa111)
[Volltext]
Preliminary experiences in the implementation of a medication therapy management based on the Arzneimittelinitiative Sachsen-Thüringen (ARMIN)
Fuchs A, Olbrich T, Maywald U[Volltext]
